New Delhi: A Complete Blood Count (CBC) is one of the most routine blood tests used to evaluate overall health by measuring red blood cells, white blood cells, and platelets. However, a frequently asked question among patients is whether this simple blood test can detect blood cancer. Dispelling common myths, cancer specialists clarify that a CBC test alone is not a definitive diagnostic tool for the disease.
According to oncologists, there are several types of blood cancers, such as lymphoma and multiple myeloma, which often do not show up in a standard CBC report. In many such cases, cancer cells are simply not visible in a routine CBC or a peripheral blood film.
Health experts emphasise that a patient’s medical history and a thorough physical examination hold far more significance than a primary blood test. Doctors actively look for specific physical symptoms, such as enlarged and palpable lymph glands, an enlarged spleen, and unexplained red, black, or blue spots on the skin (bruising or purpura). Any unusual signs of bleeding are also taken into account as critical markers that aid in diagnosing blood cancer.
When clinical suspicion arises based on these physical findings, doctors recommend more advanced and targeted diagnostic procedures. A biopsy, which involves extracting a small tissue sample from a lymph node or gland for microscopic laboratory examination, is frequently used to identify diseases like lymphoma. Similarly, a bone marrow test—where a sample is extracted using a needle, typically from the hip bone—helps in confirming conditions such as leukemia and multiple myeloma.
In today’s advanced medical landscape, molecular tests have become a crucial part of the diagnostic process. These tests deeply analyse DNA mutations and cellular changes, helping doctors understand how the cancer developed, determine its prognosis, and chart out the most effective course of treatment.
Addressing treatment options, specialists offer a beacon of hope. The majority of blood cancers now have highly effective treatments available, including modern chemotherapy and advanced immunotherapy. For high-risk patients, cutting-edge medical interventions like stem cell or bone marrow transplants, alongside CAR-T cell therapy, are being successfully utilised to control the disease and provide a significantly improved quality of life.